All-en Hiv-en News-en

Dolutegravir has FDA Approval for Treating HIV in pediatrics.

Oleh: Food and Drug Administration USA, 12 Juni 2020translated by: Caroline Thomas, 17 Juni 2020 Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination…